BeOne Medicines

“IPS is honored to have served as the lead designer and integrator in partnership with Meyer for BeOne’s new U.S. location,” said Gene Martini, Executive Vice President at IPS. “This project reflects our deep commitment to delivering innovative solutions that help our clients develop and manufacture products that improve human health.”

IPS led the design and delivery of the campus, including the biopharmaceutical manufacturing and utilities facilities, as well as critical technical systems. IPS’s comprehensive approach ensured that the project met strict regulatory requirements while maintaining operational efficiency and adaptability.

Meyer provided ground-up architecture and interior design services, in addition to overall campus design support, for BeOne’s 100,000 square-foot office and lab building, a cafeteria, and an on-site café. The new facility combines office and lab functions as well as critical mechanical and utilities systems needed to support BeOne’s clinical R&D capabilities.

“BeiGene’s new office space and clinical research and development labs highlight the company’s dedication to innovation and growth,” said Christopher Scarafile, Principal at Meyer. “Meyer is proud to have worked in collaboration with IPS to bring BeOne’s sophisticated, top-of-the-line facility to life to support the company’s mission of developing affordable and impactful oncology medicines on a global scale.”

Project partners in addition to lead campus architect IPS included developer Lincoln Equities Group, structural engineer Mainstay Engineering Group, civil engineer Van Note-Harvey Associates, and construction manager DPR Construction.